The microtubule-associated proteins (MAPs) are a set of structural proteins that bind to microtubules in vitro. Several of them occur at high levels in neurons where their expression is under strong developmen tal regulation, suggesting that they are involved in neuronal morphogenesis. Recently cDNAs for sev eral of them have been cloned and sequenced revealing their primary structures and opening the way for genetic manipulation experiments aimed at determining their functions. Such experiments have shown that there are at least two classes of MAPs that are distinguished by the amino acid sequence motifs by which they bind to tubulin. One of these classes contains three known genes, two of which have been expressed in non-neuronal cells where the proteins cause bundling of microtubules and their rearrangement within the cytoplasm. The mechan ism of this rearrangement is at present controversial. Another significant feature of these proteins is that several of them are differentially distributed within the neuronal cytoplasm; for example, some forms of MAP2 are selectively located in dendrites while in many situations MAP tau is limited to axons. In the case of MAP2, the mRNA that encodes the protein is also located in dendrites. This suggests that synthesis of MAP2 may be regulated locally in the dendritic cytoplasm. The molecular mechanism underlying the sorting of these proteins within neurons is unknown at present.
Introduction
There is now a considerable body of evidence implicating microtubule-associated proteins (MAPs) in neuronal mor phogenesis (Nunez, 1986; Matus, 1988; Tucker, 1990 ) that can be summarized as follows. When the microtubules of neurons growing in culture are depolymerized by drug treatment, both axons and dendrites lose their character istic cylindrical outline and shrink back into the cell body (Bray et al. 1978; Matus et al. 1986 ). This shapedetermining function of the microtubules probably depends on their organization into long bundles that run parallel to the axis of the neuronal process (Peters et al. 1976) . This special cytoskeletal arrangement is character ized by the presence of fine filaments that connect the bundled microtubules (Hirokawa, 1982) and immunocytochemical studies have shown that these filamentous cross bridges contain MAPs (Hirokawa et al. 1988a; SatoYoshitake et al. 1989) (Fig. 1) . Much of what has been learned recently about the properties of these molecules supports their putative role as organizers of neuronal structure. Among the more significant features are the high levels at which MAPs are expressed in neurons as compared to other cells and tissues, the selective associ ation of some of them with either axons or dendrites (Brion et al. 1988; Bernhardt and Matus, 1984; Huber et al. 1985; Binder et al. 1985) and the strong developmental regu lation that characterizes their expression in the brain (Riederer and Matus, 1985; Nunez, 1988) (Fig. 2) .
Following recent studies using molecular cloning tech niques, the precise primary structures for several of the MAPs are now known and this has provided new insights into their function. Among the structural MAPs, with which we are concerned here, two classes have been distinguished based on the amino acid motifs through which they bind to tubulin.
MAP5/MAP 1B and the initiation of neurite outgrowth
One of these two classes is represented by a single known protein that was originally described under several names, including MAP 1.2 (Aletta et al. 1988) , MAP l(x) (Calvert and Anderton, 1985) , MAP IB (Bloom etal. 1985) and MAP5 (Riederer et al. 1986 ). MAP5 appears very early during neuronal differentiation. In such diverse situations as the retinal ganglion cell and the motor neuron it is already present in the nascent axons as they emerge from the cell body, before any other known MAPs are detectable (Tucker and Matus, 1988; Tucker et al. 1988) . It continues to be expressed at high levels until the end of postnatal axon and dendrite growth, at which time MAP5 amounts drop to trace levels. This pattern of development-related expression is conserved across a wide range of vertebrates, including mammals, birds and amphibians (Riederer et al. 1991; Viereck et al. 1989; Tucker et al. 1988; Viereck and Matus, 1990) . The only places in adult brains where MAP5 is not down-regulated are areas where growth and plasticity o f neuronal connections continue throughout life, such as the olfactory bulb and hippocampus in mammals and the retino-tectal system in the frog (SatoYoshitake et al. 1989; Viereck et al. 1989; Viereck and Matus, 1990) . The expression of MAP5 is thus closely coupled to neuronal morphogenesis.
MAP5 is also expressed at increased levels in pheochromocytoma PC 12 cells when they are induced to extend neurites by treatment with nerve growth factor (NGF) (Aletta et al. 1988; Brugg and Matus, 1988) . The rise in MAP levels occurs during a latent period of 2 to 3 days before neurite outgrowth begins. However, in a sub-line of PC 12 cells that express high levels of MAP5 constitut ively, neurite outgrowth begins within 24 h after the Regulated phosphorylation also appears to be important in MAP5 function. During NGF-induced neurite out growth in PC 12 cells, not only is MAP5 expression increased but phosphorylation of the molecule also increases (Aletta et al. 1988) . MAP5 is also highly phosphorylated in the developing brain. Subsequently a decrease in its phosphorylation coincides with the downregulation of its expression during the maturation of neuronal circuitry that occurs in most areas of the brain (Riederer et al. 1991; Viereck et al. 1989) . However, it continues to be highly phosphorylated in areas where the growth of neuronal processes continues in the adult, such as the rat olfactory bulb and the frog retino-tectal system (Viereck et al. 1989; Viereck and Matus, 1990) . MAP5 is found in both axons and dendrites (Riederer et al. 1991; Sato-Yoshitake et al. 1989; Viereck et al. 1989) but both immunocytochemical and biochemical data indicate that the phosphorylated form is selectively located in axons (Riederer et al. 1991; Sato-Yoshitake et al. 1989) . Several protein kinase activities have been described in brain or neurite-bearing cell lines that are capable of phosphorylating MAP5. These include a casein kinase II-like enzyme (Diaz-Nido et al. 1988) as well novel kinase activities that have recently been described (Hoshi et al. 1990; Tsao et al. 1990) .
cDNA clones have been obtained for MAP 1B/MAP5 from mouse and rat (Noble et al. 1989; Garner et al. 1990) and the MAP5 gene shown to be located on mouse chromosome 13 (Garner et al. 1990 ). The complete protein coding region of mouse MAP1B/MAP5 has been sequenced and revealed a polypeptide of Mr 255 534, containing two kinds of repeated sequence motifs in different regions of the molecule (Noble et al. 1989) . One of these, consisting of multiple repeats of a four amino-acid sequence KKEE or KKEI/V, is apparently the sole means by which MAP 1B/MAP5 binds to tubulin, because when cDNA constructs from which these repeats had been deleted were transfected into cells the rest of the molecule did not bind to microtubules (Noble et al. 1989) . MAP 1B/MAP5 is the only protein yet discovered that contains this form of tubulin binding motif.
The M AP2/tau class of microtubule-binding proteins

Common tubulin-binding motif
The second class of MAPs are related by the possession of a tubulin-binding motif quite different to that of MAP5. In these proteins, which include MAP2, tau and MAP4 (Lee et al. 1988; Lewis et al. 1988; Goedert et al. 1991; Goedert and Jakes, 1990; Himmler, 1989) , binding to tubulin is mediated by a region of the molecule containing three or four imperfect tandem repeats of a sequence of 18 amino acids. Experiments with synthetic oligopeptides have shown that two of the tau sequences and one of the MAP2 sequences can bind to microtubules in vitro (Ennulat et al. 1989; Joly et al. 1989) . However, the affinities with which these individual sequences bind are 100-fold or more lower than those of the intact molecules, so it is likely that all of the repeat motifs together contribute to the binding of tau and MAP2. Even this is unlikely to be the full story because cDNA constructs with deletions either side of the repeat domains of MAP2 also showed significantly less avid binding than the complete molecule (Lewis and Cowan, 1990) . In addition to MAP2 and tau, a 1 90 xl0 3Mr MAP isolated from the adrenal medulla and MAP4 both contain this form of tubulin binding motif (Aizawa et al. 1989; Chapin and Bulinski, 1991) . Recently published sequence data indicates that the 1 90 xl0 3Mr MAP is probably an alternatively spliced version of MAP4 (Chapin and Bulinski, 1991) .
Developmental regulation
A common feature of this class of proteins is that their expression changes during brain development by a mechanism involving alternate splicing of the primary gene transcript (Doll et al. 1990; Kindler et al. 1990; Kosik et al. 1989; Papandrikopoulou et al. 1989; Goedert and Jakes, 1990) . In this they are distinguished from MAP1A and MAP1B, where developmental regulation involves a change in abundance of a single mRNA and hence in the level of the total protein (Garner et al. 1990 ).
The alternative splicing of MAP2 is particularly striking. There are 9 kb and 6 kb mRNAs encoding proteins that differ in size by 1372 amino acids (Doll et al. 1990; Kindler et al. 1990 ). The smaller protein, MAP2c, is expressed at similar levels to the high molecular weight form in developing brain, but drops to trace amounts during the maturation of neuronal circuitry (Riederer and Matus, 1985) . As with all MAPs, the exception is in tissues where neuronal growth continues in the adult, such as retinal photoreceptors (Tucker and Matus, 1988) , the olfactory system (Viereck et al. 1989 ) and the frog retino-tectal system (Viereck and Matus, 1990) . MAP2c consists of N-terminal and C-terminal domains of MAP2 joined together with no intervening sequence so that both contain the complete tubulin-binding domain (Fig. 3) . A sequence that acts as a binding site for the regulatory domain of type II cyclic AMP-dependent protein kinase is present in the common N-terminal sequence of both high and low molecular weight forms of the molecule (Obar et al. 1989; Rubino et al. 1989) . At the present time no function is known for the long middle domain of high molecular weight MAP2. However, the expression of developmentally regulated high and low molecular weight forms of the molecule is evidently important because it is conserved throughout the vertebrate series, from am phibia through birds to mammals, and in each case the low molecular weight form is expressed only in growing neurons.
Differential compartmentalization within neurons
A possible clue to the different functional roles of these high and low molecular weight forms comes from their different distributions within the neuronal cytoplasm (Fig. 4) . High molecular weight MAP2 is striking in that it is selectively localized in dendrites (Bernhardt and Matus, 1984) but by contrast MAP2c is also found in axons (Tucker et al. 1988) . Whether MAP2c is also present in dendrites is unknown because the absence of a unique MAP2c sequence has precluded the production of a selective antibody that could be used for immunohistochemical staining. This differential localization suggests that high molecular weight MAP2 plays a particular role in dendrites, a conclusion that is also suggested by the finding that the 9 kb MAP2 mRNA is also present in dendrites (Garner et al. 1988) . This is particularly intriguing because it raises the possibility that MAP2 levels may be regulated locally in the dendritic cytoplasm via control of its synthesis. It is tempting to speculate that this could in turn be regulated by local signals involving contact-mediated interaction of neuronal surface mol-64
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ecules, growth hormones or even synaptic transmission itself. At present there is very little experimental data on the means by which high molecular weight MAP2 gets into dendrites, but there is no shortage of proposed mechan isms. One obvious idea is that the primary event is export of the mRNA into dendrites and that the synthesis takes place after transport. The demonstration that RNA is transported into the dendrites in cultured primary neurons (Davis et al. 1987) in which MAP2 and its mRNA are selectively present (Caceres et al. 1984; Kosik and Finch, 1987; Matus et al. 1986 ) lends support to this idea. On the other hand, high molecular weight MAP2 injected into neurons spreads throughout both axons and dendrites and subsequently disappears from the axons but persists in the dendrites, prompting the suggestion that the selective location of MAP2 in dendrites is the result of a mechanism that degrades it in axons (Okabe and Hirokawa, 1989) . It also remains possible that there is a signal in the sequence of the MAP2 protein that is translated early and mediates the transport of the nascent MAP2 polypeptide together with its associated mRNA and ribosomes into the dendrite. In support of this idea is the location of the MAP2 tubulin-binding motif very close to the C terminus of the molecule, the last piece of the molecule to be translated.
A further insight into the character of the mechanism comes from recent experiments in which the distributions of several microtubule proteins in distorted Purkinje cell dendrites o f X-irradiated cerebellum were determined (Matus et al. 1990 ). This made little difference to either tubulin or MAP1A, both of which were evenly distributed throughout the cytoplasm of the dysgenic dendrites, as they are in normal cells. However, the distribution of MAP2 was significantly changed so that it became concentrated in the distal portions of the dendrites. This indicates that the location of MAP2 in these dendrites is an active mechanism that is independent of the micro tubules themselves but is instead related to dendritic morphology.
Bundling of microtubules in neuronal processes
Whether any of the MAPs are actively involved in the bundling of microtubules in neuronal processes is an issue of considerable controversy. In favour of the idea is the association of MAP2 and tau with the fine filaments that interconnect microtubules in dendrites and axons (Hirok awa et al. 1988a; Hirokawa et al. 19886) . Also relevant is the bundling of microtubules in non-neuronal cells when MAP2 or tau is expressed in them by transfection of their cDNAs (Lewis et al. 1989; Kanai et al. 1989) . On the minus side is the well-documented fact that repolymerized microtubules, whether made of total microtubule protein or reconstituted from purified tubulin and MAP2 or tau, do not spontaneously form bundles in vitro. They do, however, form linear bundles with interconnecting fine filaments when brought together by centrifugation (Kim et al. 1979; Hirokawa et al. 19886) . This can be interpreted as showing either that there is cross-linking by MAPs, albeit of very low affinity, or that the MAPs act as spacer bars between microtubules that are forced together in the limited volume inside a neuronal process or at the bottom of centrifuge tube (Brown and Berlin, 1985; Sato et al. 1988) . The lack of any difference in physical properties, such as viscosity, between concentrated solutions of MAP-contain ing microtubules as compared to pure tubulin polymers has been considered to be evidence in favour of the latter interpretation (Sato et al. 1988) .
Cowan and his colleagues have shown that the excision of a short sequence distal to the tubulin-binding domain of MAP2 eliminates microtubule bundling activity (Lewis and Cowan, 1990) . However, because the drug taxol also induces microtubule bundling it has been argued that this sequence contributes to the stabilization of microtubules that are then cross-linked by some other, ubiquitous protein (Chapin et al. 1991) . There, for the time being, rests one of the major unresolved questions concerning the molecular mechanisms of neuronal morphogensis (Fig. 5) Regulation o f microtubule binding by phosphorylation All the known MAPs are highly phosphorylated proteins, although how this influences their function is hardly understood at all. The MAPs are substrates for many phosphorylating enzymes, including several such as cyclic AMP-dependent protein kinase and calcium-calmodulin type II kinase, whose activities are modulated by the activation of neurotransmitter systems. It has been known for a long time that alterations in the phosphorylation state of MAP2 changes its binding to microtubules in vitro (Burns et al. 1984; Jameson and Caplow, 1981; Murthy and Flavin, 1983) . In recent experiments we studied the influence of phosphorylation on the interaction of MAP2 with microtubules in living cells. To do this we prepared MAP2 in different phosphoryation states by enzymatically dephosphorylating or hyperphosphorylating it in vitro and then injecting it into fibroblasts (Brugg and Matus, 1991) . This yielded the surprising result that either adding or substracting phsophate from MAP2 led to a striking decrease in its binding to c ellular microtubules. Presum ably this reflects changes in the phosphorylation at a variety of sites within the MAP2 that separately or interactively influence the molecule's affinity for tubulin.
How changes in MAP phosphorylation in living neurons might be regulated represents virtually unknown terri tory. However, two recent studies related to glutamate receptor activation provide preliminary indications. Halpain and Greengard (1990) applied glutamate receptor agonists to brain tissue slices and found that this induced a dephosphorylation of MAP2, apparently mediated by the NMDA class of receptors. That activation of glutamate receptors can manifestly alter the distribution of MAP2 relative to microtubules in primary neurons has been recently shown by Bigot et al. (1991) . In this study a variety of glutaminergic agonists were applied to cultured neurons from brain and spinal cord and the distribution of MAP2 and tubulin were determined by immunofluor escence using confocal microscopy. It was observed that stimulation of glutamate receptors led to an increase in the binding of MAP2 to microtubules.
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